Transient leukocytopenia following combination therapy for COVID-19

BACKGROUND: Combination therapy with dexamethasone, remdesivir, and baricitinib has become a promising treatment for moderate or severe COVID-19; however, we have observed transient leukocytopenia in COVID-19 patients who received combination therapy. METHODS: Twelve consecutive COVID-19 patients tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuchiya, Kazuo, Fujisawa, Tomoyuki, Mochizuka, Yasutaka, Takuma, Sho, Oishi, Kyohei, Endo, Yoshinari, Tanaka, Yuko, Fukada, Atsuki, Watanabe, Hirofumi, Katsumata, Mineo, Aoshima, Yoichiro, Inoue, Yusuke, Suzuki, Yuzo, Karayama, Masato, Hozumi, Hironao, Furuhashi, Kazuki, Enomoto, Noriyuki, Nakamura, Yutaro, Inui, Naoki, Suda, Takafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Respiratory Society. Published by Elsevier B.V. 2022
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501235/
https://www.ncbi.nlm.nih.gov/pubmed/34649811
http://dx.doi.org/10.1016/j.resinv.2021.09.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501235/
https://www.ncbi.nlm.nih.gov/pubmed/34649811
http://dx.doi.org/10.1016/j.resinv.2021.09.007

Ejemplares similares